Despite high levels of marijuana use in the U.S., little is known about the effects of recreational marijuana use on daily life. In a recent study of recreational marijuana users, marijuana use was correlated with increased impulsivity on the day of use and the following day. Participants also reported higher hostility ratings – for both themselves and their perception of others – on the day they used marijuana. This effect did not last into the next day and appeared to lessen as the study progressed. Results were not impacted by other variables measured such as alcohol or nicotine use. Read the article by clicking here: http://www.drugabuse.gov/news-events/latest-science/recreational-marijuana-use-associated-increased-impulsivity-hostility-in-daily-life <http://www.drugabuse.gov/news-events/latest-science/recreational-marijuana-use-associated-increased-impulsivity-hostility-in-daily-life>
Check out this informative article written by SARDAA Board Member Dustin DeMoss on maintaining a balanced lifestyle while living with a mental illness.
A recent paper reports findings on the reduction in life expectancy among people with mental illness
A recent paper reports findings on the reduction in life expectancy among people with mental illness relative to the general population. National Institute of Mental Health (NIMH) Director Thomas Insel discusses the magnitude and reasons for this excess mortality. http://www.nimh.nih.gov/about/director/2015/mortality-and-mental-disorders.shtml <http://www.nimh.nih.gov/about/director/2015/mortality-and-mental-disorders.shtml>
Brandon Staglin went from brilliant engineering student to institutionalized. Over the next decade he fought his way back, to help found a leading brain research organization.
Click here: http://mentalhealthchannel.tv/episode/schizophrenia to view this inspirational personal and family story.
Local Recruitment (Washington, D.C., Maryland and Virginia) – How does Puberty Affect Brain Development?
Your healthy child age 8, 12 or 13, is invited to participate in an NIH outpatient research study that examines how puberty affects brain development.
Participation includes 1-3 day outpatient visits to the NIH Clinical Center in Bethesda, Maryland every 8-10 months until age 17, for a physical examination, body measurements, questionnaires, MRI scans, blood draws, urine collection and x-rays. Participants must NOT have any chronic medical or psychiatric illnesses, nor be on any long-term medication. Parents must agree to their child’s participation.
Detailed Protocol Description: www.clinicaltrials.gov , Protocol 11-M-0251
TITLE: Long-Acting Injectable Antipsychotic Medications for Schizophrenia: Changing Our Paradigms
OVERALL DESCRIPTION: Approximately 1.1% of the population worldwide has schizophrenia, a prevalence that is relatively high due to the chronic nature and early onset of this disorder. Adherence to antipsychotic medication is crucial for minimizing the symptoms of schizophrenia and maximizing the patient’s function in society. If a patient does not adhere to a medication plan, the likelihood that the patient will relapse after being stabilized symptomatically is greatly heightened. While oral medications are a tremendous help in controlling what used to be a disease that warranted permanent institutionalization, patients often struggle with full adherence with these agents for a variety of reasons. Long-acting injectable antipsychotic drugs can be integral in assisting certain patients in managing their illness, even those with first-episode schizophrenia.
JOINTLY SPONSORED BY: University of Cincinnati College of Medicine and Haymarket Medical Education (HME)
IN COLLABORATION WITH: Schizophrenia and Related Disorders Alliance of America (SARDAA)
This educational grant is supported by Otsuka America Pharmaceutical, Inc. and Janssen Pharmaceuticals
- Charles L. Raison, MD, Professor, Department of Psychiatry, College of Medicine
- Barry and Janet Lang Professor, John and Doris Norton School of Family and Consumer Sciences, Tucson, AZ
Disclaimer: The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SARDAA.
A CD Launch Party for Tom Braxton was held at the home of SARDAA executive Director, Linda Stalters & Russ Stalters and was co-hosted by Dr. Jim and Sandy Anderson. Tom Braxton and Gianna, the vocalist has performed at the last two SARDAA Gala’s, Jazz On My Mind. Tom Braxton and his wife, Sharon, are great supporters of SARDAA. There were over 100 guests at the event asking for more. Just wait for something super special to evolve.
SARDAA volunteers were recognized for their great contributions to help with the SARDAA mission.
Many years ago, before I started making documentaries for a living, I knew there was one story I had to tell, a story I had no choice but to tell. It was happening in my own life, to my own mother. Her life seemed too strange and disturbing to be true.
‘Out of the Shadow’ was born out of my anger about the stigma and vast code of silence surrounding people with schizophrenia and their families. When I learned about how pervasive this illness is, I realized that it’s not just my mother’s story, it’s millions of people’s story. People with severe mental disorders are all around us, and I am deeply troubled by our society’s profound misunderstanding of what schizophrenia is, and of the people who are afflicted with it.
In my family no one talked about my mother’s “odd” behavior, but we all wondered why she couldn’t “pull her life together.” After decades of repeated apartment evictions and involuntary hospitalizations kept my mother on a constant cycle of unfamiliar living arrangements, psychiatric wards, doctors, social workers and medications, we finally realized that she actually was so ill that she wasn’t able to help herself.
As a filmmaker, I knew that the intimacy I had with my mother would offer unprecedented insight into the life of someone who suffers from schizophrenia, as well as their families who also have to cope with the pain and confusion of the illness. I hoped that by showing my family’s insights, I could illuminate realities and clarify misconceptions. In filming my mother, I also wanted to expose the travesties of our public health system inability to offer continuum of care, so fractured is it that decades of her life were simply lost by missed opportunities. In some small way, I hope this film will educate people who have had to care for a loved one who suffers from schizophrenia. I also hope that it will help educate those people who are not directly affected by the illness, but simply desire to better understand it.
In addition, it’s my sincere wish that this film will offer families a renewed sense of hope. It took decades for my family to learn how to take care of our mother, and help her realize some degree of potential. I have learned that some recovery IS possible if the proper supports such as housing, job training and placement and medication management are in place. Cooperation between mental health professionals and family caregivers has given our family a sense of empowerment and hope that we never before experienced. It’s also allowed Millie to realize goals she never before thought were possible.
I would like to thank SARDAA and Linda Stalters for including Out of the Shadow in their film festival. I am sorry I could not be with you at the screening but please feel free to email your comments to us at email@example.com, and check out our website www.outoftheshadow.com, for more information and educational materials.
Thank you from the bottom of my heart.